Pharmaceutical Technology

FEBRUARY 22, 2023

Developed by Sanofi and Regeneron, Praluent was approved by the FDA in July 2015. Both drugs come with a high price tag. Eventually, Amgen took the case to the Supreme Court in November 2021. However, Sanofi’s side also has significant support, highlighting the dispute’s contentious nature.

Antibody 262

Antibody Drugs Sales Protein 262

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Antibody 130

Antibody DNA Development Vaccination 130

The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global phase 2/3 trial in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. These findings give confidence that Clover’s COVID-19 vaccine candidates are suitable for further clinical development.” CHENGDU, China , Feb.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax’s CpG 1018 plus alum in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. EMERYVILLE, Calif. and CHENGDU, China , Feb.

Vaccination 52

Vaccination Vaccine Trials Protein 52

XTalks

JANUARY 28, 2022

Kimmtrak is part of a novel class of bispecific T cell immunotherapies being developed by Immunocore. Up to 50 percent of patients will develop metastatic disease, mainly spreading to the liver, making treatment difficult and limited. Kimmtrak has a price tag of $18,760 per vial, which amounts to a weekly dose.

FDA Approval 98

FDA Approval Development Licensing Licensing 98

The Pharma Data

MARCH 16, 2022

The research scientist at the Max Planck Institute for Medical Research received the award in recognition of his ground-breaking work in establishing various approaches to protein labeling in living cells that have enabled far-reaching advances in chemical and cell biology. Protein labeling (e.g. Protein labeling (e.g.

Protein 52

Protein Scientist Gene Development 52

The Pharma Data

DECEMBER 3, 2020

Based on the positive Phase 1 results reported and the unprecedented need for COVID-19 vaccines, Clover and its partners are confident to enter late-stage clinical development for both adjuvanted vaccines. 4, 2020 08:00 UTC. CHENGDU, China.–( No serious adverse events related to the vaccine candidates studied were reported.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

Delveinsight

FEBRUARY 23, 2021

The company develops transformative biologics including vaccines and therapeutics for the world’s most debilitating diseases. The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform.

In-Vitro 52

In-Vitro Vaccination Vaccine Licensing 52

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

Delveinsight

FEBRUARY 25, 2021

GuideTx will aid Beam in developing LNP-based medicines. The startup spun out of Georgia Tech in 2018 and is based on James Dahlman’s research, a professor in the university’s department of biomedical engineering and school of medicine. once Galleri becomes accessible in the second quarter of 2021.

DNA 52

DNA In-Vivo Genetics Medicine 52

pharmaphorum

JUNE 2, 2022

In 1983, the US Congress passed the Orphan Drug Act to encourage more pharmaceutical companies to engage in R&D to develop treatments for rare diseases through the offering of financial incentives. As covered in a previous article , the importance of R&D to develop treatments for rare diseases is high. The price is right.

Drugs 52

Drugs Sales Marketing Development 52

XTalks

JANUARY 7, 2022

Noodles & Company’s culinary team spent around two years developing LEANguini to offer guests a better-for-you version of their favorite dishes on the menu. Pasta is the latest food to receive a better-for-you makeover with the debut of Noodles & Company’s “LEANguini.” Menu innovation is extremely important to Noodles & Company.

Protein 52

Protein Marketing Containment Branding 52

XTalks

AUGUST 23, 2021

This is not a debate on approval,” said Stacie Weninger, PhD, president of the F-Prime Biomedical Research Initiative, in a focused topic session on the impact of drug approval on future clinical trials held on Tuesday July 27. Grill, PhD, a professor of psychiatry and human behavior in the School of Medicine at UC Irvine.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

Rethinking Clinical Trials

FEBRUARY 2, 2023

Russell, MD Assistant Professor, Department of Medicine Co-Director, Program in Medical ICU Research Division of Pulmonary, Allergy & Critical Care Medicine Assistant Medical Director, Birmingham Veterans Affairs Medical Center MICU University of Alabama at Birmingham Heersink School of Medicine Matthew W.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

XTalks

APRIL 29, 2022

The promising trial results could pose a threat to Danish drugmaker Novo Nordisk’s GLP-1 agonist drug Wegovy (semaglutide), which has dominated the obesity drug market since its launch in 2021. The drug was assessed at three different doses in Lilly’s SURMOUNT-1 Phase III trial: 5 mg, 10 mg and 15 mg. percent and 22.5 percent and 22.5

Trials 98

Trials Drugs FDA Approval Clinical Trials 98

The Pharma Data

NOVEMBER 15, 2020

. Cytiva provides FlexFactory bioprocessing upstream and downstream solutions for Clover to accelerate GMP facility development and shorten time to market. SHANGHAI , Nov. SHANGHAI , Nov.

Vaccination 52

Vaccination Vaccine Manufacturing Life Science 52

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. However, New Science is more expensive to develop. billion and $6.7

Clinical Trials 89

Clinical Trials Clinical Trials Development Marketing 89

Roots Analysis

AUGUST 28, 2022

Furthermore, several live cell imaging and non-destructive fluorescence histological methods measure limited number of biomarkers at a time and the tags introduced may interfere with the natural function of genes and proteins. 70+ spatial Genomics solutions are developed by industry and non-industry players.

Genome 52

Genome Genomics RNA Genome Project 52

XTalks

MARCH 22, 2023

Our webinars have become a key vendor-selection tool for decision-makers across the drug development pipeline — from discovery to commercialization — which is why all ten of the top ten contract research organizations (CROs) have worked with Xtalks. Roche had been a majority stakeholder in Genentech since 1990.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

pharmaphorum

FEBRUARY 26, 2021

However, it wasn’t until 1959 – 73 years and two major acquisitions later – that J&J developed its significant presence in the pharmaceutical industry. Its founder, Dr Paul Janssen, is recognised as one of the most innovative and prolific pharmaceutical researchers of the 20th century. Where it all began.

Sales 125

Sales Production Pharma Companies Marketing 125

Delveinsight

DECEMBER 3, 2020

The company anticipates the test can aid in tracking the success of vaccines and recognize people who have recovered from infection and could serve as convalescent plasma donors or help in the development of new therapies. of the time and negative results 99.98% of the time, as per Roche. Janssen buys a gene therapy asset.

Gene Therapy 52

Gene Therapy Gene Antibody Research 52

Drug Discovery World

OCTOBER 21, 2022

Flow cytometry is a well-established analytical technique that has been supporting reliable diagnostics and groundbreaking research for decades. A major breakthrough in the technology was the development of biologically active fluorescent reagents that could be detected by the instruments.

Reagent 52

Reagent Antibody Drugs Protein 52

The Pharma Data

MAY 4, 2021

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS. Tue, 05/04/2021 – 06:45. Tuesday, May 04, 2021 – 06:45am. <!–*/. First-Quarter 2021 Revenues of $14.6 First-Quarter 2021 Reported Diluted EPS (1) of $0.86, Adjusted Diluted EPS (2) of $0.93. Anonymous (not verified). –*/. <!–*/.q4default.bwalignc

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharmaceutical Technology

NOVEMBER 30, 2022

However, there has recently been a boom in interest and research in anti-obesity therapeutics. Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. The UK and US are both undergoing an obesity crisis. were overweight but not obese. million in Q3.

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

However, there has recently been a boom in interest and research in anti-obesity therapeutics. Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. The UK and US are both undergoing an obesity crisis. were overweight but not obese. million in Q3.

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246

World of DTC Marketing

JUNE 16, 2021

The May 2021 KFF Health Tracking Poll finds about two-thirds of adults say there is “not as much regulation as there should be” when it comes to limiting the price of prescription drugs. KEY POINTS: About three in ten adults report not taking their medicines as prescribed at some point in the past year because of the cost.

Drugs 180

Drugs Branding Medicine Insulin 180